[1] Huang Y, et al. Anti-oxidative stress regulator NF-E2-related factor 2 mediates the adaptive induction of antioxidant and detoxifying enzymes by lipid peroxidation metabolite 4-hydroxynonenal. Cell Biosci. 2012 Nov 28;2(1):40.
[2] Wright T, et al. The S349T mutation of SQSTM1 links Keap1/Nrf2 signalling to Pagets disease of bone. Bone. 2013 Feb;52(2):699-706.
[3] Yang YC, et al. Docosahexaenoic acid inhibition of inflammation is partially via cross-talk between Nrf2/hemeoxygenase 1 and IKK/NF-κB pathways.J NutrBiochem. 2013 Jan;24(1):204-12.
[4]Guseva NV, et al. P53 and the proteasome regulate androgen receptor activity. Cancer BiolTher. 2012 May 1;13(7):553-8.
[5] Tsai CW, et al. Carnosic acid induces the NAD(P)H: quinoneoxidoreductase 1 expression in rat clone 9 cells through the p38/nuclear factor erythroid-2 related factor 2 pathway. J Nutr. 2011 Dec;141(12):2119-25.
[6] Wang DJ, et al. Regulation of the let-7a-3 promoter by NF-κB. PLoS One. 7(2):e31240 (2012).
[7] Tran TA, et al. Lipopolysaccharide and tumor necrosis factor regulate Parkin expression via nuclear factor-kappa B. PLoS One. 6(8):e23660 (2011).
[8] Robbins D, et al. Imaging NF-κB signaling in mice for screening anticancer drugs. Methods Mol Biol. 716:169-77 (2011).
[9] Dvorák Z, et al. Differential effects of selected natural compounds with anti-inflammatory activity on the glucocorticoid receptor and NF-kappaB in HeLa cells. ChemBiol Interact. 159(2):117-28 (2006).